... advanced lungcancer (stage III) with volumetric modulated arcs using RapidArc (RA).Methods: Twenty-four consecutive patients were treated with RA. All showed locally advanced non-small cell lung cancer ... cancer- relatedmortality worldwide. Non-small celllung cancer (NSCLC) account for at least 80% of all lung tumorsand about 30% of them present with unresectable locallyadvanced disease at ... European Organization forResearch and Treatment of Cancer, National Cancer Institute of theUnited State, National Cancer Institute of Canada. J Natl Cancer Inst 2000,92:205-216.29. Low DA, Harms...
... significantanatomical changes. In the cas e of Non-Small -Cell Lung Cancer (NSCLC), lung parenchyma can significantlymodifyitsvolumeandshape[3].Asadirectconse-quence, in lungs, dose discrepancies can oc cur betweenthe ... al.: Validation of an elastic registrationtechnique to estimate anatomical lung modification in Non-Small -Cell LungCancer Tomotherapy. Radiation Oncology 2011 6:31.Submit your next manuscript ... Comparison of lung contours correspondence. kVCT slices for patient 1 with superimposed lung contours extracted from the MVCTafter a sole rigid realignment (a) and the elastic method (b). Elastic lung...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non-small CellLungCancer Collaborative Group: Chemotherapyin non small celllung cancer: a meta-analysis ... plus docetaxel as first-line chemotherapy inpatients with advanced non-small celllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20. Binder ... versus cisplatin-teniposide in patients with advanced non-small -cell lung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998,...
... Non-small -cell lungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non-small -cell lung cancer: ... in lung cancer. Clin Cancer Res 2010, 16:3349-3355.23. de Gunst MM, Gallegos-Ruiz MI, Giaccone G, Rodriguez JA: Functionalanalysis of cancer- associated EGFR mutants using a cellular assay with YFP-tagged ... series of cell lines and in tumor tissuesfrom patients with primary NSCLC, with known andunknown EGFR mutations, comparing the IHC results with DNA sequencing. They found that IHC with thesemutation-specific...
... AccessPathological complete response induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non small celllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... non-small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity. In fact, while 9% of patients with IIIA-N2NSCLC is candidate for surgery at diagnosis, with...
... clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small celllungcancer treated with concurrent chemotherapy and intensity-modulated ... of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small -cell lungcancer (NSCLC) treated with concurrent chemotherapy and three-dimensional ... factors asso-ciated with severe acute radiation pneumonitis in patients with locally advanced non-small celllungcancer treated with concurrent chemotherapy and intensity-modulated radiotherapy...
... characteristics ofpermanent human small celllungcancercell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small -cell lung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... limited-stage small celllung cancer. [http://clinicaltrials.gov/ct2/show/NCT00433563].27. Three different radiation therapy regimens in treating patients with limited-stage small celllungcancer receiving ... limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9.2. Murray N, Turrisi AT: A review of first-line treatment for small -cell lung cancer. J Thorac Oncol...
... iotherapy, Oligometastases, Non-Small CellLung Cancer BackgroundNon-small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC ... for metastatic non small celllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intentstereotactic ... SBRT.Patients withmetastases from NSCLC to any organ(s),including brain, bone, liver,orlungwereincludedinthis study. Only patients with biopsy-proven NSCLCwere included. Those with prior curative-intent...
... 115 patients with non-small cell lung cancer treated at our institution with definitive radiation therapy with or without concurrentchemotherapy (CHT). All patients were treated with 3D-CRT, ... non-small celllung cancer (NSCLC) treated with definitive radiotherapy. To determine the frequency of elective nodal failure(ENF) and in-field failure (IFF), we examined a large cohort of patients with ... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non-small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P,...
... with peripheral stage Inon-small celllung cancer. LungCancer 1999, 26:137-142.23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation inearly stage (T1-2N0) non-small celllung cancer. ... OncologyOpen AccessResearchStereotactic, single-dose irradiation of stage I non-small celllung cancer and lung metastases Peter Fritz*1, Hans-Jörg Kraus1, Werner Mühlnickel1, Udo Hammer2, ... radiation therapy for lung tumors.Methods: Fifty-eight patients underwent radiosurgery involving single-dose irradiation. With 25patients, 31 metastases in the lungs were irradiated; with each of 33...
... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non-small cell lung cancer ... attractive option for patients with early stage non-small celllungcancer (NSCLC) who are not surgical can-didates. Although primarily appealing for patients with tumors that are rapidly proliferating ... chestCT with the lung window. Planning target volume (PTV)was GTV plus a 10–15 mm margin in all directions. Elec-Example of a lung tumor in the right lower lobe easily seen by fluoroscopy with...
... chemotherapy with cisplatin and vinorelbine inpatients with locally advanced non-small -cell lung cancer. Aphase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC). LungCancer ... Milisavljevic S: Inter-fraction interval in patients with stage III non-small -cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results ... purposes)BackgroundWorldwide and in Europe lungcancer is the most com-mon cause of cancer related-death with an increasing inci-dence each year. The majority of patients has Non-Small Cell LungCancer (NSCLC) and...